Teon Therapeutics, Inc.
1 clinical trials · Sponsor
◉ Watch Teon Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| TT-816 As Monotherapy or in Combination with a PD-1 Inhibitor in Patients with Advanced Cancers (SEABEAM) (MK3475-E88) (NCT05525455) | Teon Therapeutics, Inc. | 2022-08-29 |
Track Teon Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.